Skip to main content
. 2019 May 16;52(5):e8379. doi: 10.1590/1414-431X20198379

Table 2. Haplotypes observed in the studied groups.

Haplotype Sites GC GID GMP
I II III IV V n=144 n=150 n=196
C>T C>T A>G G>T C>G (%) (%) (%)
1 T T G T G 78 (54.1) 70 (46.7) 112 (57.2)
2 C C A G C 50 (34.7) 72 (48.0) 72 (36.8)
3 T C G T C 3 (2.1) 4 (2.7) 4 (2.0)
4 T C A T C 6 (4.2) 3 (2.0) 3 (1.5)
5 T C A T G 2 (1.4) 1 (0.5)
6 T T G T C 1 (0.7) 1 (0.5)
7 T C G T G 1 (0.7) 1 (0.5)
8 C T G T G 1 (0.5)
9 C C A G G 1 (0.5)
10 T C A G C 2 (1.4) 1 (0.7)
11 T T G G G 1 (0.7)
P value 0.12a0.36b 0.13c

I: rs252643194; II: rs2517951; III: rs2643195; IV: rs2934971; V: rs1058808. GC: gastric cancer; GID: gastric inflammatory diseases; GMP: general Mexican population; n: total of chromosomes. aChi-squared test between GC vs GID. bChi-squared test between GC vs GMP. cChi-squared test between GID vs GMP.